Solana foundation company Artelo Biosciences completes $11 million private financing
Odaily reports that Nasdaq-listed Solana treasury company Artelo Biosciences has announced the private placement sale of a total of 3,188,407 common shares at a price of $3.45 per share, raising a total of $11 million. The new funds will be used for general corporate purposes and to repay some transitional debt. According to the latest data from StrategicSolanaReserve, Artelo currently holds 45,883 SOL. (Globenewswire)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Banxico: Flexible stance with upside risks – Rabobank
Planet Ventures CEO Etienne Moshevich resigns
India Relaxes Asset Management Rules: Portfolio Management Industry Approved for Overseas Investment and Short Selling Stocks for the First Time
Indian regulators announced on Thursday that they will allow the country’s $463 billion portfolio management industry to invest in overseas securities for the first time and to conduct short-selling in stock options. This move opens up new channels for India’s wealthy class to access global markets and holds significance for AI-related assets, which have attracted strong investor interest. Additionally, India will launch new portfolio management products with lower investment thresholds.
Waldencast Files to Delist Shares, Warrants From Nasdaq
Crypto prices
More
